Quality Problems More Likely in Offshore Drug Plants Transferring world-class quality control overseas can be problematic
Fri, 09/09/2011 - 10:35
Drugs produced in offshore manufacturing plants—even those run by U.S. manufacturers—pose a greater quality risk than those prepared in the mainland United States, a new study suggests.
Researchers found that drugs produced at plants located…
